BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• BioMidwest

  Simplify Healthcare Joins the Ranks of the Inc. 5000 Fastest Growing Private Companies

  Simplify Healthcare is pleased to join the 37th annual Inc. 5000 list of the fastest growing companies, reflecting our 150% growth.

  August 22, 2018

   · 

  2 min read
• Deals

  Medpace Holdings, Inc. Announces Pricing of Secondary Offering of Common Stock by Selling Shareholder at $55.50 Per Share

  Medpace Holdings, Inc. today announced the pricing of the previously announced secondary offering of 5,224,997 shares of its common stock by investment funds affiliated with Cinven Capital Management

  August 22, 2018

   · 

  4 min read
• FDA

  Dompé receives FDA approval of Oxervate™ eye drops (cenegermin-bkbj ophthalmic solution), first-in-class recombinant human nerve growth factor with potential to completely heal rare neurotrophic keratitis

  Oxervate is the first-ever application of a human nerve growth factor as drug or treatment, and is the first-ever topical biologic medication approved in ophthalmology.

  August 22, 2018

   · 

  9 min read